Glenmark Pharmaceuticals has informed about submission of media release titled, ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Abiraterone Acetate Tablets USP, 250 mg’, which is self explanatory.
The above information is a part of company’s filings submitted to BSE.